Recent ATMs

SAVA Cassava Sciences, Inc.
$200,000,000, At-the-Market
May 2023
BRTX BioRestorative Therapies Inc
$3,700,000, At-the-Market
Sole Sales Agent, April 2023
FBRT Franklin Realty Trust Inc
$200,000,000, At-the-Market
Sales Agent, April 2023
ORC Orchid Island Capital Inc
$250,000,000, At-the-Market
Sales Agent, March 2023
IVR Invesco Mortgage Capital Inc
16,000,000 shares, At-the-Market
Sales Agent, February 2023
DX Dynex Capital Inc
36,117,662 shares, At-the-Market
Sales Agent, February 2023
PIMCO
$500,000,000, PDO – At-the-Market
Sole Sales Agent, February 2023
PIMCO
$100,000,000, PCN – At-the-Market
Sole Sales Agent, January 2023
MNPR Monopar Therapeutics
$6,505,642, At-the-Market
Sole Sales Agent, January 2023
NMTC NeuroOne Medical Technologies Corp
$14,500,000, At-the-Market
Sole Sales Agent, December 2022
APTO Aptose Biosciences
$50,000,000, At-the-Market
Sole Sales Agent, December 2022
HIX Western Asset
$143,970,507, At-the-Market
Sole Sales Agent, December 2022
ACET Adicet Bio
$100,000,000, At-the-Market
Sole Sales Agent, November 2022
CTO Realty Growth
$150,000,000, At-the-Market
Sole Sales Agent, October 2022
PINE Alpine Income Property Trust
$150,000,000, At-the-Market
Sales Agent, October 2022
PIMCO
$1,000,000,000, PDI – At-the-Market
Sole Sales Agent, June 2022
DAWN Day One Biopharmaceuticals
$150,000,000, At-the-Market
Sales Agent, June 2022
PIMCO
$200,000,000, PHK – At-the-Market
Sole Sales Agent, June 2022
SIEB Siebert Financial Corp
$9,600,000, At-the-Market
Sole Sales Agent, June 2022
EFC Ellington Financial
$100,000,000, Preferred ATM
Sales Agent, January 2022
ACER Acer Therapeutics
$6,850,000, At-the-Market
Sales Agent, December 2021
Credit Suisse
$150,000,000, CIK-At-the-Market
Sole Sales Agent, November 2021
ARR Armour Residential REIT
25,661,843 shares, At-the-Market
Sales Agent, November 2021
IVR Invesco Mortgage Capital, Inc.
$236,250,000, At-the-Market
Sales Agent, November 2021
ACR Acres Commercial Realty
$2,200,000, Preferred ATM
Sole Sales Agent, October 2021
Aberdeen Asset Management
$35,000,000, FCO-At-the-Market
Sole Sales Agent, September 2021
NYMT New York Mortgage Trust Inc
$100,000,000, Preferred ATM
Sole Sales Agent, August 2021
SURF Surface Oncology
$80,000,000, At-the-Market
Sole Sales Agent, August 2021
INFI Infinity Pharmaceuticals
$75,000,000, At-the-Market
Sales Agent, July 2021
ATAX America First Multifamily Investors, L.P.
$30,000,000, At-the-Market
Sole Sales Agent, July 2021
GEO GEO Group, Inc
$300,000,000, At-the-Market
Sales Agent, June 2021
ORC Orchid Island Capital
$250,000,000, At-the-Market
Sales Agent, June 2021
Western Asset
$43,283,467, DMO-At-the-Market
Sole Sales Agent, May 2021
LIFE aTyr Pharma Inc.
$25,000,000, At-the-Market
Sole Sales Agent, March 2021
CRIS Curis, Inc.
$100,000,000, At-the-Market
Sales Agent, March 2021
ACET Adicet Bio
$75,000,000, At-the-Market
Sole Sales Agent, March 2021
OCUP Ocuphire Pharma
$40,000,000, At-the-Market
Sole Sales Agent, March 2021
ACER Acer Therapeutics
$7,700,000, At-the-Market
Sales Agent, March 2021
CNSP CNS Pharmaceuticals
$20,000,000, At-the-Market
Sales Agent, February 2021
ALRN  Aileron
$30,000,000, At-the-Market
Sales Agent, January 2021
ONVO Organovo Holdings
$50,000,000, January 2021
CMO Capstead
15,000,000 Common
3,000,000 PFD, January 2021
ALRN Aileron
$11,896,613, December 2020
ATHE Alterity Therapeutics
$50,000,000, December 2020
TCON Tracon Pharma
$50,000,000, December 2020
PCN Pimco
$100,000,000 December 2020
PFN Pimco
$175,000,000, November 2020
PFL Pimco
$120,000,000, November 2020
PTY Pimco
$600,000,000, November 2020PDI Pimco
$600,000,000, November 2020
PCI Pimco
$1,000,000,000, October 2020
PKO Pimco
$125,000,000, October 2020

ATNM Actinium Pharmaceuticals, Inc.
$200,000,000, August 2020
ORC Orchid Island Capital Inc.
$150,000,000, ATM
Sales Agent, August 2020
DX Dynex Capital Inc.
$50,000,000, August 2020
ABIO Arca Biopharma
$54,000,000, July 2020
ABIO Arca Biopharma
$14,910,600, July 2020
OSTK Overstock
$150,000,000, June 2020
SURF Surface Oncology
$50,000,000, May 2020
DMO Western Asset
$50,000,000, April 2020
AGLE Aeglea Biotherapeutics Inc
$60,000,000, April 2020
OSTK Overstock
$80,000,000, April 2020
PFL Pimco
$47,700,000, March 2020
PFN Pimco
$76,800,000, March 2020
ACER Acer Therapeutics
$10,000,000, March 2020
CRIS Curis
$30,000,000, March 2020
TCON Tracon Pharma
$1,983,015, February 2020
PKO Pimco
$125,000,000, January 2020
ORC Orchid Island Capital
$200,000,000, January 2020
MNPR Monopar Therapeutics
$19,700,000, January 2020
PCI Pimco
$1,000,000,000, December 2019
HIE Miller Howard Investments
$50,000,000, December 2019
PTY Pimco
500,000,000, November 2019
PFL Pimco
5,500,000 shares, November 2019
PFN Pimco
11,500,000 shares, November 2019
NYMT New York Mortgage Trust
$100,000,000, November 2019
OSTK Overstock
$150,000,000, November 2019
PDI Pimco
$560,000,000, November 2019
PKO Pimco
3,000,000 shares, October 2019
PTY Pimco
$500,000,000, July 2019
ALRN Aileron
$13,265,506, July 2019
INFI Infinity Pharmaceuticals
$20,000,000, June 2019
FBIO Fortress Biotech
$50,000,000, June 2019
APTS Preferred Apartment Communities
$125,000,000, June 2019
DX Dynex Capital Inc.
25,000,000 shares, May 2019
BPMX BioPharmx
$8,500,000, May 2019
SURF Surface Oncology
$30,000,000, May 2019
NYMT New York Mortgage Trust
$50,000,000, March 2019
AI Arlington Asset Investment Corp
1,647,370 shares, March 2019
IVR Invesco Mortgage Capital Inc.
7,000,000 shares, March 2019
OSTK Overstock
$52,801,423, March 2019
ABIO Arca Biopharma
$2,499,876, January 2019
ATNM Actinium Pharmaceuticals, Inc.
$75,000,000, December 2018
CLSN Celsion Corporation
$16,000,000, December 2018
PTY PIMCO
14,500,000 shares, November 2018
PFL PIMCO
5,500,000 shares, September 2018
PFN PIMCO
11,500,000 shares, September 2018
TCON Tracon Pharmaceuticals
$11,550,332, September 2018
DX Dynex Capital
$50,000,000, September 2018
RIV RiverNorth
3,300,000 shares, August 2018
SDI Standard Diversified
$6,500,000, August 2018
OSTK Overstock
$150,000,000, August 2018
ATAX America First Multifamily Investors, L.P.
$75,000,000, August 2018
PKO Pimco
3,000,000 shares, July 2018
CGO Calamos
2,685,638 shares, June 2018
PTY Pimco
12,500,000 shares, June 2018
ONVO Organovo
$50,000,000, March 2018
FPL First Trust
5,000,000 shares, March 2018
FEI First Trust
4,600,000 shares, March 2018
FEN First Trust
2,800,000 shares, March 2018
HIE Miller Howard
$50,000,000, March 2018
CHY Calamos
6,232,167 shares, March 2018
DHY Credit Suisse
16,690,564 shares, February 2018
PTIE Pain Therapeutics, Inc.
$16,900,000, December 2017
PDI Pimco
9,500,000 shares, December 2017
ATAX America First Multifamily Investors, L.P.
$75,000,000, December 2017
PRAN Prana Biotechnology
$10,019,412, November 2017
HIE Miller Howard
$50,000,000, October 2017
CHY Calamos
6,232,167 shares, October 2017
CHI Calamos
7,500,000 shares, October 2017
ABIO Arca Biopharma
$3,568,486, August 2017
DHY Credit Suisse
20,000,000 shares, July 2017
APTS Preferred Apartment Communities
$150,000,000, July 2017
FPL First Trust
5,000,000 shares, July 2017